Navigation Links
amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
Date:1/4/2008

n block the successful completion of HIV infection not only before but after the virus converts itself to DNA. Understanding the various ways in which HIV infection can be blocked may aid in the development of therapies that enhance these infection-blocking proteins in humans.

Kushol Gupta, Ph.D./Mentor: Gregory Van Duyne, Ph.D.
The University of Pennsylvania School of Medicine, Philadelphia, PA
$125,000

Biophysical and structural studies of the HIV integrase-DNA complex: In order for HIV infection to take place and to initiate reproduction, HIV must insert itself into the human DNA of the cell it has infected. The process whereby it finds its way to the nucleus of the cell and inserts itself into the DNA is incompletely understood, though researchers know that the HIV DNA must bind to the HIV enzyme integrase as well as the cell protein LEDGF. Dr. Gupta plans to use an array of technologies to generate the first atomic-level illustrations detailing the ways in which these three components bind together to accomplish the integration of HIV DNA into human DNA.

Nolwenn Jouvenet, Ph.D./Mentor: Paul Bieniasz, Ph.D.
Aaron Diamond AIDS Research Center, New York, NY
$125,000

Morphogenesis and storage of HIV-1 particles: As a final step in the process of reproduction, various components of newly made viruses gather inside the wall of the cell in which they are reproducing. From there, they are assembled into whole viruses that then either bud out of the cell or are absorbed into compartments inside the cell. It is suspected that these internal compartments that sequester the virus might contribute to the ability of the virus to persist in an infected person despite vigorous immune system and drug therapy attacks. Dr. Jouvenet will use sophisticated microscope technology to study the sequestration process and the circumstances under which the virus eventually buds out of the cell, ultimately boosting our
'/>"/>

Contact: Donald Kaplan
donald.kaplan@amfar.org
212-806-1602
amfAR, The Foundation for AIDS Research
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. amfARs MSM Initiative Seeks Proposals From Front-Line Groups Working on HIV in Developing Countries
2. amfAR Appoints New Leadership as AIDS Research Organization Extends Its Global Reach
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...k of Peers, Parents and Professionals Shares Exper...n, Employment, Recreation, More , , WASHING...a leading international disability association wor... people with significant disabilities announces th...eer resource directory accessible to people with d...
(Date:12/2/2008)...melteon show it could aid shift workers, people af...ealthDay News) -- The experimental drug tasimelteo... or night shifts, according to the results of two ...ded 39 people randomly assigned to receive either ...on, or a placebo. They were monitored for seven ni...
(Date:12/2/2008)... Dec. 2 MEDai, Inc., headquartered...rovider, has added a new module,to its existing s...and-alone,module monitors a population,s complian...ts stakeholders when there has been a deviation fr... Guidelines(TM) provides,real-time decision suppo...
(Date:12/2/2008)...s Nearly Half Have Skipped Medical Care Due to Cos...swire-USNewswire/ -- A new survey released today b...RC) highlights another troubling aspect of the cur...eek health care for themselves or their families t...men say their health has gotten worse over the pas...
Breaking Medicine News(10 mins):Health News:New Website Links People With Disabilities to Peers for Help 2Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:MEDai Evidence-Based Guideline Reporting Provides Decision Support at Point of Care 2Health News:Rising Health Costs Prompt Women to Neglect Health 2Health News:Rising Health Costs Prompt Women to Neglect Health 3Health News:Rising Health Costs Prompt Women to Neglect Health 4
...sia is catching up fast with the West. Yes, but no...tunately in cancer incidence too. Smoking, drink...ous cancers will combine with larger populations ...ous diseases to drive Asian cancer rates up 60 per...
...wo Philippines examiners were charged with corrupt...mination, officials said, in a scandal that cast ...are the first two people to be charged in connecti... commission issuing a temporary ban on the 17,000 ...
...owerful Shiite politician Abdel Aziz al-Hakim retu...receiving treatment for cancer in Tehran. Hakim, ...e parliament, spent nearly two weeks abroad in a t...cal tests in the United States and treatment in Ir...
...mputees can now breathe a sigh of relief for resea...y (MIT) in Boston have developed two robotic devic...ural, energy-efficient gaits. Dr. Hugh Herr, Assi...Biomechatronics Group at the institute, has been q...
Other Medicine News:Health News:Surge in Cancer Incidence in Asia Feared 2Health News:Surge in Cancer Incidence in Asia Feared 3Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2
(Date:12/1/2008)...de study shows the Prox1 gene is a two-way switch ...cells to be reprogrammed so that they lose their i...ls , , MEMPHIS, Tenn., Dec. 1 /PRNewswire-U...esearch Hospital have discovered that a certain di...dentity that it requires the constant expression o...
(Date:12/1/2008)...ference Call Scheduled for Tuesday, December 9 at ...L -- , , SOUTH SAN FRANCISCO, Calif., Dec....cals, Inc. (Nasdaq: SNSS ), a biopharmaceutical ...zation of new oncology therapeutics, today announc... myeloid leukemia (AML) will be presented during t...
(Date:11/30/2008)...O, Dec. 1 Abnormalities...ted in children with autism spectrum disorder by u...study presented today at the annual meeting of the... , "Using MEG, we can record the tiny magneti...," said Timothy Roberts, Ph.D., vice chair of rese...
(Date:11/26/2008)...TER, Minn., Nov. 26 Chi...are at significantly increased risk of developing ...ndings of a Mayo Clinic study published this mont...ican Academy of Pediatrics. , , The retrosp...atients with strabismus (misaligned eyes) and comp...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Eye Divergence in Children Triples Risk of Mental Illness 2Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 1Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 2Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 3Wide Ranging Study of National News Reveals Health News Comprises Less Than Four Percent of All Coverage 30401 4Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 1Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 2Essentialis Completes Patient Enrollment in Phase 2 Trial of DDCR for Treatment of Dyslipidemia 3477 3Ultrasound waves aid in rapid treatment of DVT 30399 1Ultrasound waves aid in rapid treatment of DVT 30399 2UT Southwestern researchers develop new strategy for broad spectrum anti viral drugs 30397 1UT Southwestern researchers develop new strategy for broad spectrum anti viral drugs 30397 2
...ansurethral Resection,is Well Tolerated in Phase 2...2007 /PRNewswire-FirstCall/ --,Spectrum Pharmaceut... study of EOquin, in non-invasive bladder cancer a...L)-1620 and satraplatin,at the annual meeting of t...t the Los Angeles Convention Center in Los Angeles...
..., 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS)... at Loma Linda University Medical Center,National...rsity,showing that one of the Company,s metallopor...ection of healthy normal cells in mice,with prosta... study,also showed that the compound did not inter...
Other Medicine Technology:Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 2Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 3Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 4Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 5Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 6Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 7Spectrum Pharmaceuticals Announces Data From Three Oncology,Programs Presented at the American Association of Cancer Research,Annual Meeting 8Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3
...sively for the airlines industry:, ,AirSeps A...ured for the airlines to assist their supplemental...everal overseas airlines. With the US governments ...on specific Boeing commercial aircraft, AirSep set...
...p's LifeStyle Portable Oxygen Concentrator is the ...nywhere. At less than 10 lbs (4.5 kg), this unit w... and highly active oxygen patient., ,Operatin...logies of both an oxygen concentrator and an oxyge...
...ers up to 10 LPM of oxygen reducing the delivery c...ts. The M10 is engineered to reduce the cost of pr...parts than any other concentrator on the market. F...p you to reduce expenditure on accessories and unn...
The Hudson RCI oxygen conserving cannula incorporates a patented "split prong" nose design and two oxygen supply tubes with standard connectors. This design provides the utmost control and comfort in
Medicine Products: